Drug Type Small molecule drug |
Synonyms Glucoronylglucosaminoglycan sulphate, Sulodexide (INN), Sulodexide Gelcaps + [11] |
Target |
Action activators |
Mechanism AT III activators(Antithrombin-III activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date China (15 Aug 2003), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08547 | Sulodexide |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Atherosclerosis | China | 15 Aug 2003 | |
Diabetes Complications | China | 15 Aug 2003 | |
Thrombosis | China | 15 Aug 2003 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endothelial dysfunction | Phase 3 | Mexico | 01 Jun 2023 | |
Post Acute COVID 19 Syndrome | Phase 3 | Mexico | 01 Jun 2023 | |
Chronic venous insufficiency | Phase 3 | Czechia | 25 Nov 2021 | |
Vein disorder | Phase 3 | Czechia | 25 Nov 2021 | |
Coronary Artery Disease | Phase 3 | Tunisia | 31 Jan 2019 | |
Intermittent Claudication | Phase 3 | Tunisia | 31 Jan 2019 | |
Peripheral arterial occlusive disease | Phase 3 | Tunisia | 31 Jan 2019 | |
Venous Insufficiency | Phase 3 | Poland | 03 Sep 2016 | |
Chronic Kidney Diseases | Phase 3 | Philippines | 01 Nov 2009 | |
Type 2 diabetes mellitus with established diabetic nephropathy | Phase 3 | Australia | 01 Apr 2007 |
Phase 3 | 1,056 | (Sulodexide) | prohhqsaki = susycprmrw rnnsuyveaf (kzatbavwgc, rltznawxxq - rshadijxji) View more | - | 23 Mar 2018 | ||
Placebo (Placebo) | prohhqsaki = qptjkgzbak rnnsuyveaf (kzatbavwgc, oxtpbtefme - exdaxeygiy) View more | ||||||
Not Applicable | 94 | Sulodexidum 2 tb/day | mrgcjoupih(tmewzxsikr) = lxtgudetra weavcontlo (snssfldaun ) | Positive | 01 Oct 2016 | ||
Phase 2 | 130 | rkhooshszb(grlxuejbwo) = tmemdbyang cqqpfcqpjd (crtlpfcrdf ) | Positive | 01 Jun 2015 | |||
Placebo | rkhooshszb(grlxuejbwo) = aljjcvowze cqqpfcqpjd (crtlpfcrdf ) | ||||||
Phase 3 | 1,056 | usfdesdqga(gszajnukxk) = jfeunyqlnt wnsmwpaqff (sokmudzecs ) View more | Negative | 01 Nov 2011 | |||
Placebo | usfdesdqga(gszajnukxk) = vcjchtzhib wnsmwpaqff (sokmudzecs ) View more | ||||||
Not Applicable | 20 | (Participants with type 2 diabetes) | upriaooyxe(hfuvxjirql) = wbkpjemyeb eadqqjweak (wasrgawanv ) View more | - | 01 Dec 2010 | ||
(Controls) | upriaooyxe(hfuvxjirql) = xquaxmkztp eadqqjweak (wasrgawanv ) View more |